Pioneering Targeted Antibodies to Revolutionize Gut Health and Transform Human Well-Being
Precision Science. Personalized Health. A New Era of Microbiome Innovation.
At ImmuniMed, we are pioneering the development of targeted oral dose antibodies to precisely modulate the gut microbiome. Our groundbreaking approach unlocks the potential to treat and prevent a wide range of diseases by restoring balance to the microbial ecosystem within us.
About us
Our Mission: Redefining Health Through the Gut Microbiome
At ImmuniMed, we believe the future of medicine lies in understanding and harnessing the gut microbiome. Our mission is to develop innovative, targeted oral antibody therapies that restore microbial balance and address the root causes of disease. By combining cutting-edge antibody engineering with microbiome science, we are creating a new paradigm in healthcare—one that is precise, personalized, and transformative.
Key Points:
Precision Targeting: Our proprietary antibody technology selectively modulates specific microbial populations in the gut.
Oral Delivery: Convenient, non-invasive, and designed for maximum efficacy.
Transformative Potential: Initially targeting the only preventive treatment against C. difficile infection.
We’re Not Anti-Vax, We’re Antibodies.
Safe Effective Affordable options to vaccines, antibiotics and other treatments.
A SEA Change in Medicine.
